Security key
H57830103
NLS Pharmaceutics Ltd. - Common Share, Par Value CHF 0.03 Per Share (NLSP)
CUSIP: H57830103
Q2 2023 13F Holders as of 30 Jun 2023
- Security type / class
- Equity / Common Share, Par Value CHF 0.03 Per Share
- Total 13F shares
- 6,461,209
- Total 13F value
- $7,107,161
- Share change
- +95,268
- SEC-reported price per share
- $1.10
- Number of holders
- 9
- Value change
- +$95,119
- Number of buys
- 5
- Number of sells
- 2
- Shares outstanding
- 4,220,689
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2023
Institutions
9
Top holders
9
NLSP full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2023
Previous quarter: Q1 2023
NewcelX Ltd. SEC filings
NewcelX Ltd. company facts
Broader feeds
Reporting periods
Holder history for CUSIP H57830103
Recent filing periods:
Ownership snapshot
Top reported holders of NLSP - NLS Pharmaceutics Ltd. - Common Share, Par Value CHF 0.03 Per Share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BVF INC/IL
Disclosed value leader
BVF INC/IL
Comparable rows
7/7
Latest evidence
31 Mar 2023
13F
Lead comparable stake: 136%
Showing 1-6 of 7 holder rows.
Quick read
BVF INC/IL leads the comparable SEC ownership view at 136%.
7 of 7 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BVF INC/IL's linked filing trail.
Comparable ownership
Top 5
BVF INC/IL
136%
Affinity Asset Advisors, LLC
8.2%
J. Goldman & Co LP
4.9%
RENAISSANCE TECHNOLOGIES LLC
0.76%
SUSQUEHANNA INTERNATIONAL GROUP, LLP
0.56%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 7 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BVF INC/IL |
13F
Company
|
136%
|
$8,678,160
5,747,126 shares
|
— | 31 Mar 2023 |
| Affinity Asset Advisors, LLC |
13F
Company
|
8.2%
|
$519,574
344,089 shares
|
— | 31 Mar 2023 |
| J. Goldman & Co LP |
13F
Company
|
4.9%
|
$311,212
204,745 shares
|
— | 31 Mar 2023 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.76%
|
$49,000
32,100 shares
|
— | 31 Mar 2023 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
0.56%
|
$35,378
23,429 shares
|
— | 31 Mar 2023 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.34%
|
$21,686
14,362 shares
|
— | 31 Mar 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
9
Shares
6,461,209
Rows available
9
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
7
Q2 2023 holders
9
Holder diff
2
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 value | Q2 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend